These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1281 related items for PubMed ID: 27830113

  • 1. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM, van der Grond J, Hafkemeijer A, Rombouts SA, Roos RA.
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [Abstract] [Full Text] [Related]

  • 2. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC.
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, TRACK-HD investigators.
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [Abstract] [Full Text] [Related]

  • 5. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.
    Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S, TRACK-HD Investigators.
    Hum Brain Mapp; 2016 Jan; 37(1):67-80. PubMed ID: 26453902
    [Abstract] [Full Text] [Related]

  • 6. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S, Sampedro F, Horta-Barba A, Perez-Perez J, Pagonabarraga J, Gomez-Anson B, Kulisevsky J.
    Neuroimage Clin; 2020 Jan; 28():102415. PubMed ID: 32979842
    [Abstract] [Full Text] [Related]

  • 7. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators.
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [Abstract] [Full Text] [Related]

  • 8. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
    Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P.
    Neuroimage; 2006 Oct 01; 32(4):1562-75. PubMed ID: 16875847
    [Abstract] [Full Text] [Related]

  • 9. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S, TRACK-HD Investigators.
    Neuroimage Clin; 2018 Oct 01; 17():312-324. PubMed ID: 29527479
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.
    J Neurol Neurosurg Psychiatry; 2008 Feb 01; 79(2):130-5. PubMed ID: 17615168
    [Abstract] [Full Text] [Related]

  • 11. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR, Stout JC, Domínguez D JF, Salmon L, Churchyard A, Chua P, Georgiou-Karistianis N, Egan GF.
    Neurobiol Dis; 2014 May 01; 65():180-7. PubMed ID: 24480090
    [Abstract] [Full Text] [Related]

  • 12. Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington's Disease.
    Kronenbuerger M, Hua J, Bang JYA, Ultz KE, Miao X, Zhang X, Pekar JJ, van Zijl PCM, Duan W, Margolis RL, Ross CA.
    Neurodegener Dis; 2019 May 01; 19(2):78-87. PubMed ID: 31412344
    [Abstract] [Full Text] [Related]

  • 13. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF, Stout JC, Poudel G, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N.
    Br J Psychiatry; 2016 Jun 01; 208(6):571-8. PubMed ID: 26678864
    [Abstract] [Full Text] [Related]

  • 14. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ, Seunarine KK, Gibbard CR, McColgan P, Draganski B, Friston K, Clark CA, Tabrizi SJ.
    Hum Brain Mapp; 2015 May 01; 36(5):1728-40. PubMed ID: 25640796
    [Abstract] [Full Text] [Related]

  • 15. Gray matter alterations in Huntington's disease: A meta-analysis of VBM neuroimaging studies.
    Wang X, Li Y, Li B, Shang H, Yang J.
    J Neurosci Res; 2024 Jul 01; 102(7):e25366. PubMed ID: 38953592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.